Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3399134rdf:typepubmed:Citationlld:pubmed
pubmed-article:3399134lifeskim:mentionsumls-concept:C0030095lld:lifeskim
pubmed-article:3399134lifeskim:mentionsumls-concept:C0521390lld:lifeskim
pubmed-article:3399134lifeskim:mentionsumls-concept:C0027358lld:lifeskim
pubmed-article:3399134lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:3399134lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3399134lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:3399134lifeskim:mentionsumls-concept:C0036085lld:lifeskim
pubmed-article:3399134lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:3399134lifeskim:mentionsumls-concept:C0442120lld:lifeskim
pubmed-article:3399134lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:3399134lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:3399134lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:3399134pubmed:issue1lld:pubmed
pubmed-article:3399134pubmed:dateCreated1988-8-26lld:pubmed
pubmed-article:3399134pubmed:abstractTextUrethane anaesthetized male rats were given an i.p. injection of hypertonic saline to increase plasma osmotic pressure. This injection resulted in significantly elevated plasma oxytocin levels and increased discharge activity of putative oxytocin cells in the supraoptic nucleus. Subsequent injection of naloxone (1 mg/kg) i.v. resulted in a similarly large increase in plasma oxytocin, but did not affect the discharge activity of putative oxytocin neurones. The results suggest that, following an i.p. injection of hypertonic saline, endogenous opioids act at the neurosecretory terminals to partially inhibit oxytocin release.lld:pubmed
pubmed-article:3399134pubmed:languageenglld:pubmed
pubmed-article:3399134pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3399134pubmed:citationSubsetIMlld:pubmed
pubmed-article:3399134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3399134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3399134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3399134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3399134pubmed:statusMEDLINElld:pubmed
pubmed-article:3399134pubmed:monthMaylld:pubmed
pubmed-article:3399134pubmed:issn0304-3940lld:pubmed
pubmed-article:3399134pubmed:authorpubmed-author:LenkCClld:pubmed
pubmed-article:3399134pubmed:authorpubmed-author:WaySSlld:pubmed
pubmed-article:3399134pubmed:authorpubmed-author:ShibukiKKlld:pubmed
pubmed-article:3399134pubmed:issnTypePrintlld:pubmed
pubmed-article:3399134pubmed:day16lld:pubmed
pubmed-article:3399134pubmed:volume88lld:pubmed
pubmed-article:3399134pubmed:ownerNLMlld:pubmed
pubmed-article:3399134pubmed:authorsCompleteYlld:pubmed
pubmed-article:3399134pubmed:pagination75-80lld:pubmed
pubmed-article:3399134pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3399134pubmed:meshHeadingpubmed-meshheading:3399134-...lld:pubmed
pubmed-article:3399134pubmed:meshHeadingpubmed-meshheading:3399134-...lld:pubmed
pubmed-article:3399134pubmed:meshHeadingpubmed-meshheading:3399134-...lld:pubmed
pubmed-article:3399134pubmed:meshHeadingpubmed-meshheading:3399134-...lld:pubmed
pubmed-article:3399134pubmed:meshHeadingpubmed-meshheading:3399134-...lld:pubmed
pubmed-article:3399134pubmed:meshHeadingpubmed-meshheading:3399134-...lld:pubmed
pubmed-article:3399134pubmed:meshHeadingpubmed-meshheading:3399134-...lld:pubmed
pubmed-article:3399134pubmed:meshHeadingpubmed-meshheading:3399134-...lld:pubmed
pubmed-article:3399134pubmed:meshHeadingpubmed-meshheading:3399134-...lld:pubmed
pubmed-article:3399134pubmed:meshHeadingpubmed-meshheading:3399134-...lld:pubmed
pubmed-article:3399134pubmed:meshHeadingpubmed-meshheading:3399134-...lld:pubmed
pubmed-article:3399134pubmed:meshHeadingpubmed-meshheading:3399134-...lld:pubmed
pubmed-article:3399134pubmed:year1988lld:pubmed
pubmed-article:3399134pubmed:articleTitleEffects of naloxone and of intraperitoneal hypertonic saline upon oxytocin release and upon supraoptic neuronal activity.lld:pubmed
pubmed-article:3399134pubmed:affiliationDepartment of Neuroendocrinology, AFRC Institute of Animal Physiology and Genetics Research, Babraham, Cambridge, U.K.lld:pubmed
pubmed-article:3399134pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3399134pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3399134lld:pubmed